Position in RGC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,909
-$1,863 QoQ
Shares Held
642
+182.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 35 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026OSAIC HOLDINGS, INC. holds $44,501,431 across 71 Drug Manufacturers - Specialty & Generic names. RGC ranks #51 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
217,692 | $7,375,403 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
10,752 | $5,825,755 | |
| 3 | ZTS |
Zoetis Inc.
|
76,124 | $5,470,270 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
110,062 | $3,815,848 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
22,617 | $3,811,866 | |
| 6 | LQDA |
Liquidia Corp
|
42,666 | $3,401,759 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
134,620 | $2,330,270 | |
| 8 | VTRS |
Viatris Inc
|
116,264 | $1,846,269 |
All Filings in RGC
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,909 | 642 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,772 | 227 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,767 | 227 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,507 | 227 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,237 | 190 | Shares | Defined | 2025-09-04 | |
| No filing history on record for this holder in this stock. | ||||||